PharVision Advisers’s Ooma OOMA Stock Holding History

PharVision Advisers’s Portfolio OOMA Stock Details OOMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,806	Closed	-$150K	–	489
2025 Q4	$150K	Sell	12,806 -23,440	-65%	-$267K	0.08%	612
2025 Q3	$435K	Buy	+36,246	New	+$444K	0.24%	49

Other funds holding OOMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

PharVision Advisers's OOMA Position: Q1 2026 in Review

PharVision Advisers sold out of Ooma (OOMA) in Q1 2026, closing a stake of 12,806 shares — an estimated $150K sold.

PharVision Advisers first reported a position in OOMA in Q3 2025 and held it in 2 quarters. The position peaked at $435K in Q3 2025. 157 funds tracked by Wall St. Rank hold OOMA as of Q1 2026.

PharVision Advisers reported no remaining Ooma position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 12,806 Ooma shares in Q1 2026, an estimated $150K.
PharVision Advisers first reported a position in Ooma in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Ooma position peaked at $435K in Q3 2025.
157 funds tracked by Wall St. Rank held Ooma as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.